INS and amyloidosis: Preparations of insulin and its analogues, entering the body, in addition to the direct therapeutic effect in the treatment of diabetes mellitus, can provoke undesirable effects, which are known as insulin amyloidosis and toxic effects on cells at injection sites [88,89].